📢 Anacura, a Ghent-based company, has acquired OHMX.bio, a University spin-off specializing in advanced -omics technology. This expands Anacura’s services in drug discovery and diagnostics research. Anacura aims to provide personalized and evidence-based laboratory solutions and strengthen its service offering to the biotech community. OHMX.bio combines multi-omics technologies with bio-informatics for discovery and quality control of biologics and advanced therapy medicinal products. Anacura has over 250 employees in Evergem and Bruges.
📢 Anacura Expands Services with OHMXbio Acquisition
Anacura, a company offering medical and pharmaceutical analytical services, has acquired OHMX.bio, a University spin-off specializing in advanced -omics technology. The acquisition expands Anacura’s services to include drug discovery and diagnostics research. OHMX.bio combines multi-omic technologies with advanced bioinformatics to accelerate the discovery process and quality control of biologics and advanced therapy medicinal products. The acquisition enhances Anacura’s ability to provide innovative healthcare services and strengthens its service offering to the biotech community.
